EUVIMEDEUVIMED entdecken
Crossref

CXCL12+ LSEC–CXCR4+ CAF axis drives post-transplant hepatocellular carcinoma recurrence under tacrolimus immunosuppression

Tomohiko Ikehara, Masaya Onishi, Takeo Toshima, Taro Tobo, Hiroko Oshima, Kiyotaka Hosoda, Takashi Ofuchi, Akinori Tsujimoto, Yu Takahashi, Koto Kawata, Shohei Shibuta, Yuki Ando und 12 weitere

Journal of Gastroenterology · 17.11.2026

DOI: 10.1007/s00535-026-02541-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 17.11.2026. Verfasst von Tomohiko Ikehara und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Kyushu University Beppu Hospital, 4546 Tsurumibaru, Beppu, Oita, 874-0838, Japan. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CXCL12–CXCR4 axisHepatocellular carcinoma recurrenceLiver sinusoidal endothelial cellsLiver transplantationTumor immune microenvironment

Autor:innen und Institutionen

  • Department of Surgery, Kyushu University Beppu Hospital, 4546 Tsurumibaru, Beppu, Oita, 874-0838, Japan.
  • Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
  • Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.
  • Department of Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Clinical Laboratory Medicine and Pathology, Kyushu University Beppu Hospital, Beppu, Oita, Japan.
  • Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Takeda Science Foundation
  • Princess Takamatsu Cancer Research Fund
  • OITA Cancer Research Foundation

Zitieren

APA

Ikehara, T., Onishi, M., Toshima, T., Tobo, T., Oshima, H., Hosoda, K., Ofuchi, T., Tsujimoto, A., Takahashi, Y., Kawata, K., Shibuta, S., Ando, Y., Hu, Q., Yonemura, Y., Shimizu, A., Otsu, H., Oshima, M., Suzuki, Y., Masuda, T., …, & Mimori, K. (2026). CXCL12+ LSEC–CXCR4+ CAF axis drives post-transplant hepatocellular carcinoma recurrence under tacrolimus immunosuppression. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02541-y

Vancouver

Ikehara T, Onishi M, Toshima T, Tobo T, Oshima H, Hosoda K, et al. CXCL12+ LSEC–CXCR4+ CAF axis drives post-transplant hepatocellular carcinoma recurrence under tacrolimus immunosuppression. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02541-y

BibTeX
@article{Ikehara2026,
  author = {Ikehara, Tomohiko and Onishi, Masaya and Toshima, Takeo and Tobo, Taro and Oshima, Hiroko and Hosoda, Kiyotaka and Ofuchi, Takashi and Tsujimoto, Akinori and Takahashi, Yu and Kawata, Koto and Shibuta, Shohei and Ando, Yuki and Hu, Qingjiang and Yonemura, Yusuke and Shimizu, Akira and Otsu, Hajime and Oshima, Masanobu and Suzuki, Yutaka and Masuda, Takaaki and Fujimoto, Yuka and Hasegawa, Kiyoshi and Yoshizumi, Tomoharu and Soejima, Yuji and Mimori, Koshi},
  title = {CXCL12+ LSEC–CXCR4+ CAF axis drives post-transplant hepatocellular carcinoma recurrence under tacrolimus immunosuppression},
  journal = {Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s00535-026-02541-y}
}
Kostenlos starten →